Latest Stock Market News

Prashant Jain of 3P Investment Managers suggests a diversified portfolio approach due to low valuation dispersion, noting no sector trades below 15-year average multiples, with premiums mainly in capital goods and consumer discretionary. He anticipates India s economy to grow around 6% with corporate profit growth of 10-12%, while cautioning against overpricing narratives like Atmanirbhar Bharat.

Bharat Petroleum Corporation (BPCL) and Sembcorp Green Hydrogen India have formed a 50:50 joint venture to develop renewable energy and green hydrogen projects across India. This collaboration aims to produce and sell renewable energy, green hydrogen, and its derivatives, potentially including green ammonia.

Vodafone Idea has allotted 3,695 crore equity shares to DIPAM, converting spectrum auction dues into equity, resulting in the government holding a 48.99% stake. SEBI granted an exemption for the acquisition, aiming to improve the telecom provider s liquidity. The company s paid-up equity share capital has significantly increased following this allotment.

Cochin Shipyard shares: Cochin Shipyard stated that the partnership will enhance maritime infrastructure, create jobs, and support India s ambition to achieve self-reliance in the sector through the Atmanirbhar Bharat initiative.

A closing price above the VWAP indicates that the stock ended the day higher than its average traded price, weighted by volume.

JM Financial has a hold call on Titan, setting a target price of Rs 3,550. Titan s Q3FY25 consolidated total income rose 21.92% QoQ and 24.95% YoY, with a net profit after tax of Rs 1047.00 crore. While revenue growth is expected to be strong, margin pressure and gold lease costs may lead to flat profit after tax year over year.

There is a significant focus on global diversification using Liberalised Remittance Scheme (LRS), Overseas Portfolio Investment (OPI)/ Overseas Direct Investment (ODI) route and integration of investments with migration decisions.

We do not predict market levels, what we focus on is valuations which are still above average. Small and mid-cap are expensive while large caps are in the fair value zone. We have an internal model for asset allocation which is used for equity allocation in some of our asset allocation strategies and that model is suggesting around 60-65% asset allocation to equity.

Indian pharmaceutical companies are crucial to the U.S. healthcare system, filling four out of every ten prescriptions in 2022. Reports indicate that Indian medicines saved the U.S. healthcare system USD 219 billion in 2022 and USD 1.3 trillion from 2013 to 2022. Over the next five years, Indian generics are expected to contribute an additional USD 1.3 trillion in savings.